TRIM58 and acute myeloid leukemia: Through a comprehensive analysis of DNA methylation and gene expression profiles in AML cells treated with the neddylation inhibitor MLN4924, they found that low TRIM58 expression and high promoter methylation are associated with poor prognosis.